From memory ( and I could be wrong) at the start of the trials the FDA did have questions for us and when they were asked PAR explained the process of how they had to go through the question, process a reply then send it to the FDA. The FDA then have another 30 days to accept it or to ask further questions or clarification and the 30 + day cycle starts over again. Therefore the need to be precise was paramount to avoid a long drawn out submission.
If I am incorrect, I apologise and would appreciate a correction.
Voddy
From memory ( and I could be wrong) at the start of the trials...
-
- There are more pages in this discussion • 161 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add PAR (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
25.5¢ |
Change
-0.005(1.92%) |
Mkt cap ! $89.19M | |||
| Open | High | Low | Value | Volume |
| 27.0¢ | 27.0¢ | 25.5¢ | $261.4K | 990.7K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 9999 | 25.5¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 26.0¢ | 9445 | 1 |
View Market Depth
| Last trade - 16.10pm 28/06/2024 (20 minute delay) ? |
| PAR (ASX) Chart |